Physician

Reuben Kristian Ellis, M.D.

According to 2025 Medicare claims, Reuben Ellis, M.D. (NPI: 1114969110) practices nephrology in the Macon-Bibb County, GA market, with the plurality of this provider's patient population coming from Bibb, GA. This provider's primary affiliated billing organization is PHYSICIAN CONSULTANTS OF GEORGIA (NPI: 1962762708; TIN: 45-2405642) and primary practice location at 31201-6546. Ellis is affiliated with the TC2, LLC (ACO ID: A3365), participating under the MSSP model.

Ellis' data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 341 traditional Medicare patients, billed 9,389 HCPCS/CPT codes, and received $1,035,627 in Medicare payments. The top billing code was 99223 (Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes). Part D data shows 2,986 prescription claims across 345 beneficiaries totaling $946,100 in drug costs, led by Xphozah (Tenapanor Hcl). DME data shows 137 claims. Open Payments data shows 70 records totaling $2,291. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has fallen sharply in recent years, from $1,681,199 to $1,035,627. Concurrently, Part D prescription costs have moved up and down with repeated peaks and valleys, starting at $188,869 and ending at $946,100. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	610	72,050	$1,681,199
2016	625	46,479	$1,657,435
2017	593	46,051	$1,475,644
2018	633	42,650	$1,436,285
2019	587	48,799	$1,254,311
2020	590	25,891	$1,343,338
2021	478	15,847	$888,549
2022	377	5,167	$594,331
2023	336	5,048	$631,349
2024	341	9,389	$1,035,627

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	235	2,672	$188,869
2016	249	3,284	$597,355
2017	268	3,208	$849,455
2018	308	2,772	$1,143,897
2019	331	2,930	$809,428
2020	315	2,626	$569,997
2021	349	2,884	$273,861
2022	313	2,367	$592,237
2023	282	2,199	$1,035,175
2024	345	2,986	$946,100

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	N/R	14	$214
2016	N/R	N/R	N/R
2017	N/R	11	$213
2018	N/R	97	$4,931
2019	N/R	N/R	N/R
2020	N/R	52	$1,431
2021	N/R	48	$1,143
2022	N/R	83	$1,692
2023	N/R	78	$2,021
2024	N/R	137	$2,664

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
99223	Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes	75	104	$120
99233	Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes	95	1,188	$84
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	126	305	$83
99213	Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more	125	300	$59
36415	Insertion of needle into vein for collection of blood sample	150	372	$9

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Xphozah	Tenapanor Hcl	30	1,560	$155,864
Velphoro	Sucroferric Oxyhydroxide	20	585	$44,939
Jardiance	Empagliflozin	58	2,160	$41,715
Auryxia	Ferric Citrate	30	1,036	$35,748
Eliquis	Apixaban	43	1,830	$35,746

Top 5 DME services in 2024

By Total Medicare Payment Amount.

HCPCS Code	HCPCS Description	Supplier Rental Indicator	Total Supplier Beneficiaries	Total Supplier Claims	Total Medicare Payment Amount
Q0511	Pharmacy supply fee for oral anti-cancer, oral anti-emetic or immunosuppressive drug(s); for the first prescription in a 30-day period	N	N/R	34	$621
Q0512	Pharmacy supply fee for oral anti-cancer, oral anti-emetic or immunosuppressive drug(s); for a subsequent prescription in a 30-day period	N	N/R	32	$602
J7518	Mycophenolic acid, oral, 180 mg	N	N/R	13	$593
J7507	Tacrolimus, immediate release, oral, 1 mg	N	N/R	13	$480
J7517	Mycophenolate mofetil, oral, 250 mg	N	N/R	23	$344

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	70	$2,291	Abbott Laboratories
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Reuben Kristian Ellis, M.D.?

Tedicare shows public-source Medicare data for Reuben Kristian Ellis, M.D. (NPI 1114969110), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Reuben Kristian Ellis, M.D. have ACO affiliation data?

Reuben Kristian Ellis, M.D. is shown with ACO affiliation data for TC2, LLC (MSSP, ACO ID A3365).

What billing organization is linked to Reuben Kristian Ellis, M.D.?

Reuben Kristian Ellis, M.D. is linked to PHYSICIAN CONSULTANTS OF GEORGIA (billing NPI 1962762708) in the available physician profile data.

Does Reuben Kristian Ellis, M.D. have Open Payments data?

Reuben Kristian Ellis, M.D. has 70 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.